1.
von Stebut E, Reich K, Thaci D, Koenig W, Pinter A, Korber A, Rassaf T, Waisman A, Mani V, Yates D, Frueh J, Sieder C, Melzer N, Gori T. Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. J of Skin [Internet]. 2018 Feb. 23 [cited 2024 Jul. 3];2(S1):S20. Available from: https://jofskin.org/33014/index.php/skin/article/view/290